The development of new drugs is time consuming, expensive and risky. Often, what appear to be promising drugs fail in the clinic, after much time and money has already been invested. A common reason ...

Scott Nevil is an experienced writer and editor with a demonstrated history of publishing content for Investopedia. He goes in-depth to create informative and actionable content around monetary policy ...